Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of VKORC1 and Cytochrome P450 CYP2C9 Gene Polymorphisms and Management of Warfarin Dose Using Pharmacogenetic Data

NCT00970892 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT00970892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00970892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of VKORC1 and Cytochrome P450 CYP2C9 Gene Polymorphisms and Management of Warfarin Dose Using Pharmacogenetic Data
Lead sponsor
Ankara University
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2009
Completion date
December 31, 2012
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac thrombus, cardiomyopathy (ischemic or dilated), deep vein thrombosis, heart valve replacement (mechanical or biological with af), peripheral vascular disease, pulmonary embolism